Clinical Trials
11 trialsNCT05108805 2025-03-27
Chimeric Antigen Receptor (CAR) T Cell Therapy With YESCARTA in the Outpatient Setting
Vanderbilt-Ingram Cancer Center
Phase 4 Completed
NCT05786989 2023-03-28
Selinexor Combined With R-GemOx as Second-line Treatment in Patients With Diffuse Large B-cell Lymphoma
Chongqing University Cancer Hospital
Phase 4 Unknown
NCT02752815 2022-12-05
Reduced Chemotherapy in Low Risk DLBCL
Ruijin Hospital
Phase 4 Unknown
NCT05518383 2022-08-26
B-cell Mature Non-Hodgkin's Lymphoma Treatment Protocol in Children and Adolescents 2021
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Phase 4 Recruiting
NCT01990534 2021-04-09
A Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Hodgkin Lymphoma
Takeda
Phase 4 Completed
NCT00003398 2019-10-17
Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
University of Maryland, Baltimore
Phase 4 Completed
NCT03376958 2019-07-25
Apatinib for Relapsed and Refractory Diffuse Large B Cell Lymphoma
Zhengzhou University
Phase 4 Completed
NCT03579082 2018-09-14
A Clinical Trial of Decitabine in Relapse and Refractory Diffuse Large B Cell Lymphoma
Zhengzhou University
Phase 4 Unknown
NCT03513601 2018-05-01
Treatment of Elderly Patients With Diffuse Large B-cell Lymphoma
Zhengzhou University
Phase 4 Unknown
NCT01949818 2015-12-30
Treatment of Diffuse Large B Cell Lymphoma
Zhengzhou University
Phase 4 Unknown
NCT00466258 2009-11-25
LINFOTARGAM
PETHEMA Foundation
Phase 4 Completed